Episode 216: Update on Broluciziumab Safety Including HAWK/HARRIER Phase 3 Trial Data

Drs. Thomas Albini, Aleksandra Rachitskaya, and Charles Wykoff of the Vit-Buckle Society join for a group discussion of brolucizimab safety data including a discussion of idiopathic ocular inflammation and arterial occlusions from HAWK/HARRIER Phase 3 trials, post-market reports of adverse events, and approach to utilizing brolucizumab going forward.